Work

Abstract 3098: Linker cleavable enzymes determine anti-tumor activity of trastuzumab deruxtecan in HER2-positive lung cancer and HER2-low breast cancer

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-3098

Authors: Akari Shiraishi, Asumi Iesato, Yuki Takahashi, Ken Uchibori, Tomo Osako, Reo Maruyama, Makoto Nishio, Ryohei Katayama

Institutions: Japanese Foundation For Cancer Research, Toppan (Japan)

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409625032

Cites:

Cited by: 1

Related to: 10